Contact
searchSearch
HMP Global
Login
News
Liquid Biopsy Detects Acquired Resistance Mutations Among Patients With ALK-Positive Non-Small Cell Lung Cancer Treated With Alectinib
11/03/2025
Stephanie Holland
According to preliminary results from the TANGIBLE study, liquid biopsy demonstrates high sensitivity and feasibility for detecting ALK gene alterations and resistance mechanisms among patients with ALK-rearranged non-small cell lung cancer...
According to preliminary results from the TANGIBLE study, liquid biopsy demonstrates high sensitivity and feasibility for detecting ALK gene alterations and resistance mechanisms among patients with ALK-rearranged non-small cell lung cancer...
According to preliminary results...
11/03/2025
Oncology
News
Persistent Oncogenic Drivers on Serial Liquid Biopsies Linked to Shorter Progression-Free Survival in TKI-Treated Non-Small Cell Lung Cancer
11/03/2025
Stephanie Holland
Results from a retrospective analysis show that persistence of oncogenic driver mutations detected through serial liquid biopsies is linked to shorter progression-free survival in patients with non-small cell lung cancer receiving tyrosine...
Results from a retrospective analysis show that persistence of oncogenic driver mutations detected through serial liquid biopsies is linked to shorter progression-free survival in patients with non-small cell lung cancer receiving tyrosine...
Results from a retrospective...
11/03/2025
Oncology
News
Platelet Transcriptomic Profiling Identifies Resistance-Associated Signatures Among Patients With Non-Small Cell Lung Cancer Treated With Pembrolizumab-Based Regimens
11/03/2025
Stephanie Holland
According to findings from a translational study, platelet gene expression profiling has identified key molecular markers associated with resistance to first-line immunotherapy-based regimens in patients with advanced non-small cell lung...
According to findings from a translational study, platelet gene expression profiling has identified key molecular markers associated with resistance to first-line immunotherapy-based regimens in patients with advanced non-small cell lung...
According to findings from a...
11/03/2025
Oncology
News
Early ctDNA Decrease Predicts Immunotherapy Response in Advanced Non-Small Cell Lung Cancer
11/03/2025
Stephanie Holland
According to results from a prospective study, early decreases in ctDNA after initiating pembrolizumab with or without chemotherapy can predict response to treatment in patients with advanced non-small cell lung cancer.
According to results from a prospective study, early decreases in ctDNA after initiating pembrolizumab with or without chemotherapy can predict response to treatment in patients with advanced non-small cell lung cancer.
According to results from a...
11/03/2025
Oncology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use